Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.191
-0.009 (-4.60%)
At close: Apr 28, 2026, 4:00 PM EDT
0.195
+0.004 (2.31%)
Pre-market: Apr 29, 2026, 8:45 AM EDT
Ernexa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6 | 9 | 15 | 10 | 17 | 217 | |
| Market Cap Growth | -51.95% | -37.64% | 55.53% | -41.17% | -92.39% | - | |
| Enterprise Value | 4 | 7 | 49 | 45 | 6 | 196 | |
| Last Close Price | 0.19 | 1.20 | 4.41 | 26.92 | 48.30 | 1251.00 | |
| PS Ratio | - | - | 25.95 | 142.82 | - | - | |
| PB Ratio | 0.62 | 3.92 | 8.88 | 4.35 | 1.36 | 8.51 | |
| P/TBV Ratio | 15.63 | 26.46 | - | 51.66 | 1.64 | 9.25 | |
| EV/Sales Ratio | - | - | 83.40 | 658.24 | - | - | |
| Debt / Equity Ratio | 0.20 | 0.20 | 0.40 | 18.74 | 0.10 | 0.11 | |
| Net Debt / Equity Ratio | -0.58 | -0.58 | -0.61 | 15.35 | -0.85 | -0.56 | |
| Net Debt / EBITDA Ratio | 0.15 | 0.15 | 0.06 | -1.66 | 0.38 | 0.52 | |
| Net Debt / FCF Ratio | 0.20 | 0.20 | 0.06 | -1.68 | 0.48 | 0.60 | |
| Asset Turnover | - | - | 0.02 | 0.00 | - | - | |
| Quick Ratio | 0.88 | 0.88 | 0.74 | 1.22 | 1.62 | 4.81 | |
| Current Ratio | 1.01 | 1.01 | 0.80 | 1.46 | 1.79 | 5.10 | |
| Return on Equity (ROE) | -686.69% | -686.69% | -2264.31% | -302.20% | -130.70% | -739.07% | |
| Return on Assets (ROA) | -104.92% | -104.92% | -39.64% | -36.19% | -63.25% | -77.17% | |
| Return on Capital Employed (ROCE) | -342.50% | -342.50% | -740.00% | -48.60% | -186.20% | -98.50% | |
| Earnings Yield | -253.48% | -149.53% | -294.88% | -223.12% | -148.88% | -56.47% | |
| FCF Yield | -126.81% | -74.89% | -107.29% | -210.34% | -128.86% | -10.89% | |
| Buyback Yield / Dilution | -593.08% | -593.08% | -156.87% | -74.17% | -40.92% | -146.19% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.